Ajax-Loading

Merck & Company Inc - Total Other Income Expense Net

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Other-Income-Expense-Net" stands at -1.58 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 03/31/2023.

Merck & Company Inc's third quarter result of -0.811 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -46.65 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of -0.811 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -865.09 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of -1.58 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -139.15 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -1.37 Billion United States Dollars compared to the value the year prior.
The 1 year change is -1.37 Billion United States Dollars.
The 3 year change is 0.128 Billion United States Dollars.
The 5 year change is -1.97 Billion United States Dollars.
The 10 year change is -10.85 Billion United States Dollars.

The Serie's long term average value is -0.0717 Billion United States Dollars. It's latest available value, on 09/30/2025, is -1.50 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 03/31/2016, to it's latest available value, on 09/30/2025, is +0.572 Billion.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2014, to it's latest available value, on 09/30/2025, is -12.18 Billion.

Total Other Income Expense Net for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Total Other Income Expense Net905,699,262,464.00
LogoJohnson & Johnson - Total Other Income Expense Net486,508,953,600.00
LogoAbbVie Inc - Total Other Income Expense Net399,570,305,024.00
LogoRoche Holding AG - Total Other Income Expense Net317,433,206,677.55
LogoAstraZeneca PLC - Total Other Income Expense Net280,205,508,085.11